Reduced secretion of MMPs, plasminogen activators and TIMPS from prostate cancer cells derived by repeated metastasis

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 39-42

  Sehgal, Inder ^a   Forbes, Katie ^a   Webb, Matthew A ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Adhesion; MMP; PC 3M; PC 3MM2; PC3; Tissue plasminogen activator; Urokinase plasminogen activator

Indexed keywords

MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BONE METASTASIS; CANCER CELL; CELL ADHESION; ENDOTHELIUM CELL; ENZYME RELEASE; EXTRACELLULAR MATRIX; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; STROMA CELL; TUMOR GROWTH;

ANIMALS; CELL ADHESION; CELL DIVISION; FIBRONECTINS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; PROSTATIC NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0037231167     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC and Chung LW: Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54: 2577-81, 1994.
2. Delworth MG, Nishioka K, Pettaway CA, Gutman M, Killion JJ, von Eschenbach AC and Fidler IJ: Systemic administration of 4-amidinoindanon-1-(2′-amidino)-hydrazone, a new inhibitor of S-adenosylmethionine decarboxylase, produces cytostasis of human prostate cancer in athymic nude mice. Intl J Oncology 6: 293-299:1995.
3. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ and Fidler IJ: Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clinical Cancer Res 2: 1627-1636, 1996.
4. Greene GF, Kitadal Y, Pettaway CA, von Eschenbach AC, Bucana CD and Fidler IJ: Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Path 150: 1571-1582, 1997.
5. Stearns ME and Wang M: Regulation of kinesin expression and type IV collagenase secretion in invasive human prostate PC-3 tumor sublines. Cancer Res 51: 5866-5875, 1991.
6. Sehgal I, Baley P and Thompson TC: Transforming growth factor beta 1 stimulates contrasting responses in metastatic vs. Primary mouse prostate cancer-derived cell lines in vivo. Cancer Res 56: 3359-3365, 1996.
7. Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A and Bologna M: Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Clin Exp Metastasis 16: 513-28, 1998.
8. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostate carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979.
9. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM and Massague J: Growth inhibition by TGFβ linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185, 1990.
10. Stidwill RP and Christen M: Cell alteration of fibronectin affinity during differentiation modulates the in vitro migration velocities of Hydra nematocytes. Cell Motil Cytoskeleton 41: 68-73, 1998.
11. Surin B, Rouillard D and Bauvois B. Interactions between human monocytes and fibronectin are suppressed by interferons beta and gamma, but not alpha: Correlation with Rho-paxillin signaling. Int J of Mol Med 10: 25-31, 2002.
12. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF and Jesty J: Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 75: 780-6, 1998.
13. Wandel E, Raschke A, Hildebrandt G, Eberle J, Dummer R, Anderegg U and Saalbach A. Fibroblasts enhance the invasive capacity of melanoma cells in vitro. Arch Dermatol Res 293: 601-8, 2002.